Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThe implementation plan published on 23rd June 2021 sets out the first year of activities towards delivering the vision for The Future of UK Clinical Research Delivery.
Public consultation Following several internal rounds of consultation and extensive discussion between PIC/S Members on draft versions of PIC/S Annex 16, the PIC/S Committee recently agreed to proceed to Step 2 of the PIC/S consultation process.
EMA has published its 2020 annual report that provides an overview of the Agency’s major achievements and contributions to public health in Europe.
EMA is establishing a coordination centre to provide timely and reliable evidence on the use, safety and effectiveness of medicines and vaccines, from real world healthcare databases across the EU. The initiative is called Data Analysis and Real World Interrogation Network, or simply #DARWINEU. It will connect the European medicines regulatory network to the European Commission's European Health Data Space (EHDS), an initiative to promote better exchange and access to different types of health data. DARWIN EU will enable EMA and national competent authorities in the European medicines regulatory network to draw on valid and reliable evidence whenever needed throughout the lifecycle of a medicinal product.
Regulation (EU) 2017/745 on medical devices becomes applicable in the European Union today, 26 May 2021.
Meeting highlights for PRAC held 7th - 10th June 2021
Reflection paper on forecasting demand for medicinal products in the EU/EEA Published 3rd June 2021
Open Consultation - Survey
Great Britain Marketing Authorisations (MAs) for Centrally Authorised Products (CAPs) An updated list of PLGB numbers for the grandfathering of CAP MAs.
A framework for restarting NIHR research activities which have been paused due to COVID-19